Cargando…
Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer
BACKGROUND: Proton therapy is a promising advancement in radiation oncology especially in terms of reducing normal tissue toxicity, although it is currently expensive and of limited availability. Here we estimated the individual quality of life benefit and cost-effectiveness of proton therapy in pat...
Autores principales: | Brodin, N. Patrik, Kabarriti, Rafi, Schechter, Clyde B., Pankuch, Mark, Gondi, Vinai, Kalnicki, Shalom, Garg, Madhur K., Tomé, Wolfgang A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819210/ https://www.ncbi.nlm.nih.gov/pubmed/33478544 http://dx.doi.org/10.1186/s13014-021-01745-1 |
Ejemplares similares
-
A positron emission tomography radiomic signature for distant metastases risk in oropharyngeal cancer patients treated with definitive chemoradiotherapy
por: Brodin, N. Patrik, et al.
Publicado: (2022) -
Origin of Locoregional Recurrences After Definitive Intensity-modulated Radiation Therapy (IMRT) for Laryngeal Cancer Determined Based on Follow-up PET/CT Imaging
por: Kabarriti, Rafi, et al.
Publicado: (2019) -
Reply to Chowdhary et al
por: Kabarriti, Rafi, et al.
Publicado: (2020) -
Extent of Prior Lung Irradiation and Mortality in COVID-19 Patients With a Cancer History
por: Kabarriti, Rafi, et al.
Publicado: (2020) -
Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York
por: Kabarriti, Rafi, et al.
Publicado: (2020)